Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression

Deficiency of tumor suppressor FLCN leads to the activation of the mTOR signaling pathway in human BHD-associated renal cell carcinomas (RCC). We have previously developed a renal distal tubule-collecting duct-Henle's loop-specific Flcn knockout (KO) mouse model (Flcn(flox/flox)/Ksp-Cre). This...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Wu, Mingsong, Si, Shuhui, Li, Yan, Schoen, Susan, Xiao, Guang-Qian, Li, Xueying, Teh, Bin Tean, Wu, Guan, Chen, Jindong
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741728/
https://ncbi.nlm.nih.gov/pubmed/26418749
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars